NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
DE2830469A1
(de)
*
|
1978-07-11 |
1980-01-24 |
Bayer Ag |
Herstellung von l-desoxy-nojirimycin und n-substituierten derivaten
|
DE2835069A1
(de)
*
|
1978-08-10 |
1980-02-21 |
Bayer Ag |
N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung
|
DE2839309A1
(de)
*
|
1978-09-09 |
1980-03-27 |
Bayer Ag |
3,4,5-trihydroxypiperidin-derivate
|
DE2848117A1
(de)
*
|
1978-11-06 |
1980-05-14 |
Bayer Ag |
Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
|
JPS55118415A
(en)
*
|
1979-02-28 |
1980-09-11 |
Pii Papahadojiyopo Dometoriosu |
Method of encapsulating biologically active substance in lipoid cell
|
DE2925943A1
(de)
*
|
1979-06-27 |
1981-01-29 |
Bayer Ag |
1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE2942365A1
(de)
*
|
1979-10-19 |
1981-05-14 |
Bayer Ag, 5090 Leverkusen |
2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
JPS56108768A
(en)
*
|
1980-01-28 |
1981-08-28 |
Nippon Shinyaku Co Ltd |
Cinnamylmoranoline derivative
|
JPS56108767A
(en)
*
|
1980-01-28 |
1981-08-28 |
Nippon Shinyaku Co Ltd |
Bismoranoline derivative
|
DE3007078A1
(de)
*
|
1980-02-26 |
1981-09-10 |
Bayer Ag, 5090 Leverkusen |
Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
|
DE3620645A1
(de)
*
|
1985-12-20 |
1987-07-02 |
Bayer Ag |
3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
|
US5192772A
(en)
*
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
US5089520A
(en)
*
|
1987-12-21 |
1992-02-18 |
Monsanto Company |
Method of inhibiting virus
|
US4849430A
(en)
*
|
1988-03-09 |
1989-07-18 |
Monsanto Company |
Method of inhibiting virus
|
US4999360A
(en)
*
|
1987-12-21 |
1991-03-12 |
Monsanto Company |
Method of inhibiting virus
|
EP0344383A1
(en)
*
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Novel alpha-Glucosidase inhibitors
|
US5043416A
(en)
*
|
1988-09-26 |
1991-08-27 |
Monsanto Company |
Method of inhibiting virus
|
US4973602A
(en)
*
|
1988-11-03 |
1990-11-27 |
G. D. Searle & Co. |
Antiviral compounds and a method of use thereas
|
US4937357A
(en)
*
|
1988-11-03 |
1990-06-26 |
G. D. Searle & Co. |
Intermediates for antiviral compounds
|
US5310745A
(en)
*
|
1988-11-03 |
1994-05-10 |
G. D. Searle & Co. |
Antiviral compounds
|
US5003072A
(en)
*
|
1988-11-03 |
1991-03-26 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-D-glucitol derivatives
|
US4876268A
(en)
*
|
1988-11-03 |
1989-10-24 |
G. D. Searle & Co. |
Antiviral compounds and use thereof
|
US5221746A
(en)
*
|
1988-11-03 |
1993-06-22 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-D-glucitol derivatives
|
US5144037A
(en)
*
|
1988-11-03 |
1992-09-01 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-d-glucitol derivatives
|
US4957926A
(en)
*
|
1988-12-22 |
1990-09-18 |
Monsanto Company |
Method of treating herpesviruses
|
US5103008A
(en)
*
|
1989-08-17 |
1992-04-07 |
Monsanto Company |
Compound, N-butyl-deoxynojirimycin-6-phosphate
|
US5043273A
(en)
*
|
1989-08-17 |
1991-08-27 |
Monsanto Company |
Phosphorylated glycosidase inhibitor prodrugs
|
US5536732A
(en)
*
|
1990-04-27 |
1996-07-16 |
Merrell Pharmaceuticals Inc. |
N-derivatives of 1-deoxy nojirimycin
|
EP0453692A1
(en)
*
|
1990-04-27 |
1991-10-30 |
Merrell Dow Pharmaceuticals Inc. |
Novel nojirimycin derivatives
|
US5252587A
(en)
*
|
1990-04-27 |
1993-10-12 |
Merrell Dow Pharmaceuticals, Inc. |
N-derivatives of 1-deoxy nojirimycin
|
US5151519A
(en)
*
|
1990-05-07 |
1992-09-29 |
G. D. Searle & Co. |
Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
|
US5504078A
(en)
*
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
US5342951A
(en)
*
|
1992-04-01 |
1994-08-30 |
G.D. Searle & Co. |
2- and 3-sulfur derivatives of 1,5-iminosugars
|
US5798366A
(en)
*
|
1993-05-13 |
1998-08-25 |
Monsanto Company |
Method for treatment of CNS-involved lysosomal storage diseases
|
US6291657B1
(en)
*
|
1993-05-13 |
2001-09-18 |
Monsanto Company |
Deoxygalactonojirimycin derivatives
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
AU1403795A
(en)
*
|
1994-01-13 |
1995-08-01 |
G.D. Searle & Co. |
Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections
|
US20030100532A1
(en)
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
ES2216327T3
(es)
|
1997-11-10 |
2004-10-16 |
G.D. SEARLE & CO. |
Uso de iminoazucares alquilados para tratar la resistencia a multiples a farmacos.
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
JP2002502875A
(ja)
|
1998-02-12 |
2002-01-29 |
ジー・ディー・サール・アンド・カンパニー |
肝炎ウイルス感染症を処置するためのn−置換−1,5−ジデオキシ−1,5−イミノ−d−グルシトール化合物の使用
|
HK1043311A1
(zh)
*
|
1999-02-12 |
2002-09-13 |
G.D. Searle & Co. |
使用替代-1,5-二脱氧-1,5-亚氨基-d-glucitol化合物治疗肝炎病毒感染
|
JP2003505501A
(ja)
|
1999-02-12 |
2003-02-12 |
ジー・ディー・サール・アンド・カンパニー |
肝炎ウィルス感染の処置のためのグルカミン化合物
|
GB9909066D0
(en)
|
1999-04-20 |
1999-06-16 |
Oxford Glycosciences Uk Ltd |
Therapies
|
US20050032841A1
(en)
*
|
1999-04-20 |
2005-02-10 |
Steven Walkley |
Therapeutic compositions and methods of treating glycolipid storage related disorders
|
AU2004242777B2
(en)
*
|
2003-05-30 |
2011-05-12 |
Ranbaxy Laboratories Limited |
Substituted pyrrole derivatives and their use as HMG-Co inhibitors
|
BRPI0517701A8
(pt)
|
2004-11-10 |
2018-01-23 |
Genzyme Corp |
métodos de tratamento de diabetes mellitus
|
BRPI0618379A2
(pt)
*
|
2005-11-08 |
2011-08-30 |
Ranbaxy Lab Ltd |
processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
|
CL2007000667A1
(es)
*
|
2006-03-14 |
2008-03-14 |
Ranbaxi Lab Ltd |
Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
|
WO2007134086A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Genzyme Corporation |
Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis
|
WO2008010087A2
(en)
*
|
2006-07-14 |
2008-01-24 |
Ranbaxy Laboratories Limited |
Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
|
CA2666814A1
(en)
*
|
2006-08-21 |
2008-05-29 |
United Therapeutics Corporation |
Combination therapy for treatment of viral infections
|
US8097728B2
(en)
*
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
EP2594562B1
(en)
|
2007-05-31 |
2016-07-20 |
Genzyme Corporation |
2-acylaminopropanol-type glucosylceramide synthase inhibitors
|
CA2701649C
(en)
*
|
2007-10-05 |
2016-05-24 |
Genzyme Corporation |
Method of treating polycystic kidney diseases with ceramide derivatives
|
JP2011529500A
(ja)
|
2008-07-28 |
2011-12-08 |
ジェンザイム コーポレーション |
虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害
|
WO2010039256A1
(en)
|
2008-10-03 |
2010-04-08 |
Genzyme Corporation |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
|
ES2579628T3
(es)
|
2009-02-23 |
2016-08-12 |
Emergent Virology Llc |
Iminoazúcares y métodos de tratamiento de enfermedades virales
|
CN102625660B
(zh)
*
|
2009-02-24 |
2015-03-11 |
联合治疗公司 |
亚氨基糖以及治疗沙粒病毒感染的方法
|
ES2524361T3
(es)
*
|
2009-06-12 |
2014-12-05 |
United Therapeutics Corporation |
Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
|
EP2473046B1
(en)
*
|
2009-09-04 |
2014-10-22 |
United Therapeutics Corporation |
Iminosugars for their use in the treatment of filoviral diseases
|
JP5653438B2
(ja)
*
|
2009-09-04 |
2015-01-14 |
ユナイテッド セラピューティクス コーポレイション |
オルトミクソウイルス感染の治療方法
|
CA2772807A1
(en)
*
|
2009-09-04 |
2011-03-10 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods of treating poxviral infections
|
WO2017192599A1
(en)
|
2016-05-02 |
2017-11-09 |
Florida State University Research Foundation, Inc. |
Treatment of zika virus infections using alpha-glucosidase inhibitors
|
WO2021168483A2
(en)
|
2020-02-21 |
2021-08-26 |
Florida State University Research Foundation, Inc. |
Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
|